Zhen Lou
Publications by Year
Research Areas
Coagulation, Bradykinin, Polyphosphates, and Angioedema, Pharmacogenetics and Drug Metabolism, Peptidase Inhibition and Analysis, Toxic Organic Pollutants Impact, Gastrointestinal motility and disorders
Most-Cited Works
- → Determination of Degradation Pathways and Kinetics of Acyl Glucuronides by NMR Spectroscopy(2007)67 cited
- → Properties and regional expression of a CYP3A-like protein in channel catfish intestine(2005)60 cited
- → Discovery of a Parenteral Small Molecule Coagulation Factor XIa Inhibitor Clinical Candidate (BMS-962212)(2017)51 cited
- → Structure-Based Design of Macrocyclic Factor XIa Inhibitors: Discovery of the Macrocyclic Amide Linker(2017)39 cited
- → Role of Residue 363 and 206 in Conversion of Cytochrome P450 2B1 from a Steroid 16-Hydroxylase to a 15α-Hydroxylase(1994)35 cited
- → LC–MS/MS Multiplexed Assay for The Quantitation of A Therapeutic Protein BMS-986089 and The Target Protein Myostatin(2016)27 cited
- → N-(6,7-Dichloro-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-N-alkylsulfonamides as peripherally restricted N-methyl-d-aspartate receptor antagonists for the treatment of pain(2007)24 cited
- → Discovery of a High Affinity, Orally Bioavailable Macrocyclic FXIa Inhibitor with Antithrombotic Activity in Preclinical Species(2020)22 cited
- → Potent, Orally Bioavailable, and Efficacious Macrocyclic Inhibitors of Factor XIa. Discovery of Pyridine-Based Macrocycles Possessing Phenylazole Carboxamide P1 Groups(2019)22 cited
- → The Clinical Development of Taldefgrobep Alfa: An Anti-Myostatin Adnectin for the Treatment of Duchenne Muscular Dystrophy(2024)21 cited